MARKET INTRODUCTIONUrinary Tract Infection is the most common hospital-acquired infection caused by patient's urethral catheters or invasive manipulation in the urogenital tract, which allows microbe to enter into the bladder and enlivens proliferation by providing a sustainable environment. Hospital acquired urinary tract infection are liable for over 50% of the infections. MARKET DYNAMICSThe Hospital Acquired Urinary Tract Infection Market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of Hospital Acquired UTIs, technological advancement in testing devices and focused disease management. Nevertheless, strict regulatory policies and introduction of new testing devices substituting the products may affect the growth of the market during the forecast period. MARKET SCOPEThe "Global Hospital Acquired Urinary Tract Infection Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Acquired Urinary Tract Infection market with detailed market segmentation by Product, Application, Technology, Disease, End User and geography. The global Hospital Acquired Urinary Tract Infection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hospital Acquired Urinary Tract Infection market players and offers key trends and opportunities in the market.MARKET SEGMENTATIONThe global Hospital Acquired Urinary Tract Infection market is segmented on the basis of Product, Application, Technology, Disease and End user. Based on Product the market is segmented into microbial testing instruments, reagents and consumables, infection prevention, and surveillance software. The microbial testing instruments are further sub-segmented into automated microbial identification systems, polymerase chain reaction (PCR) instruments, mass spectrometers, microarrays, polystainers, flow cytometers, and others. Based on Application the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology the market is segmented into Phenotypic Methods and Genotypic Methods. The phenotypic methods is further sub segmented into phage-based assays, colorimetric methods, and nitrate reductase assay. The Genotypic methods is further sub-segmented into DNA sequencing, solid-phase hybridization techniques, polymerase chain reaction techniques, microarrays. Based on Disease the market is segmented into Hospital Acquired Pneumonia, Bloodstream infections, Surgical Site infections, gastrointestinal infections, Urinary Tract Infections and Others. Based on End User the market is segmented into Hospitals and Intensive Care Units. REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital Acquired Urinary Tract Infection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Urinary Tract Infection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.The report analyzes factors affecting Hospital Acquired Urinary Tract Infection market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Urinary Tract Infection market in these regions.MARKET PLAYERSThe reports cover key developments in the Hospital Acquired Urinary Tract Infection Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hospital Acquired Urinary Tract Infection Market are anticipated to lucrative growth opportunities in the future with the rising demand for Hospital Acquired Urinary Tract Infection in the global market. Below mentioned is the list of few companies engaged in the Hospital Acquired Urinary Tract Infection market. The report also includes the profiles of key Hospital Acquired Urinary Tract Infection market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.- Becton
- Dickinson and Company
- Steris Corporation
- Getinge Group
- Kimberly-Clark Corporation
- Cantel Medical
- Biomerieux SA
- Belimed AG
- 3M Company
- Sterigenics International LLC.,
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Acquired Urinary Tract Infection Market - By Product
1.3.2 Hospital Acquired Urinary Tract Infection Market - By Application
1.3.3 Hospital Acquired Urinary Tract Infection Market - By Technology
1.3.4 Hospital Acquired Urinary Tract Infection Market - By Disease
1.3.5 Hospital Acquired Urinary Tract Infection Market - By End User
1.3.6 Hospital Acquired Urinary Tract Infection Market - By Region
1.3.6.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL ACQUIRED URINARY TRACT INFECTION - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL ACQUIRED URINARY TRACT INFECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. MICROBIAL TESTING INSTRUMENTS
7.3.1. Overview
7.3.2. Microbial Testing Instruments Market Forecast and Analysis
7.3.3. Automated Microbial Identification Systems Market
7.3.3.1. Overview
7.3.3.2. Automated Microbial Identification Systems Market Forecast and Analysis
7.3.4. Polymerase Chain Reaction (PCR) instruments Market
7.3.4.1. Overview
7.3.4.2. Polymerase Chain Reaction (PCR) instruments Market Forecast and Analysis
7.3.5. Mass Spectrometers Market
7.3.5.1. Overview
7.3.5.2. Mass Spectrometers Market Forecast and Analysis
7.3.6. Microarrays Market
7.3.6.1. Overview
7.3.6.2. Microarrays Market Forecast and Analysis
7.3.7. Polystainers Market
7.3.7.1. Overview
7.3.7.2. Polystainers Market Forecast and Analysis
7.3.8. Flow Cytometers Market
7.3.8.1. Overview
7.3.8.2. Flow Cytometers Market Forecast and Analysis
7.3.9. Others Market
7.3.9.1. Overview
7.3.9.2. Others Market Forecast and Analysis
7.4. REAGENTS AND CONSUMABLES, INFECTION PREVENTION, SURVEILLANCE SOFTWARE
7.4.1. Overview
7.4.2. reagents and consumables, infection prevention, surveillance software Market Forecast and Analysis
8. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DISEASE TESTING, DRUG-RESISTANCE TESTING
8.3.1. Overview
8.3.2. Disease Testing, Drug-Resistance Testing Market Forecast and Analysis
9. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. PHENOTYPIC METHODS
9.3.1. Overview
9.3.2. Phenotypic Methods Market Forecast and Analysis
9.3.3. Phage-based Assays Market
9.3.3.1. Overview
9.3.3.2. Phage-based Assays Market Forecast and Analysis
9.3.4. Colorimetric Methods Market
9.3.4.1. Overview
9.3.4.2. Colorimetric Methods Market Forecast and Analysis
9.3.5. Nitrate Reductase Assay Market
9.3.5.1. Overview
9.3.5.2. Nitrate Reductase Assay Market Forecast and Analysis
9.4. GENOTYPIC METHODS
9.4.1. Overview
9.4.2. Genotypic Methods Market Forecast and Analysis
9.4.3. DNA Sequencing Market
9.4.3.1. Overview
9.4.3.2. DNA Sequencing Market Forecast and Analysis
9.4.4. Solid-phase Hybridization Techniques Market
9.4.4.1. Overview
9.4.4.2. Solid-phase Hybridization Techniques Market Forecast and Analysis
9.4.5. Polymerase Chain Reaction Techniques Market
9.4.5.1. Overview
9.4.5.2. Polymerase Chain Reaction Techniques Market Forecast and Analysis
9.4.6. Microarrays Market
9.4.6.1. Overview
9.4.6.2. Microarrays Market Forecast and Analysis
9.5.
9.5.1. Overview
9.5.2. Market Forecast and Analysis
9.6.
9.6.1. Overview
9.6.2. Market Forecast and Analysis
10. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
10.1. OVERVIEW
10.2. DISEASE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL ACQUIRED PNEUMONIA, BLOODSTREAM INFECTIONS, SURGICAL SITE INFECTIONS, GASTROINTESTINAL INFECTIONS, URINARY TRACT INFECTIONS, OTHERS
10.3.1. Overview
10.3.2. Hospital Acquired Pneumonia, Bloodstream infections, Surgical Site infections, Gastrointestinal infections, Urinary Tract Infections, Others Market Forecast and Analysis
11. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS, INTENSIVE CARE UNITS.
11.3.1. Overview
11.3.2. Hospitals, Intensive Care Units. Market Forecast and Analysis
12. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Hospital Acquired Urinary Tract Infection Market Overview
12.1.2 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis
12.1.3 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Product
12.1.4 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Application
12.1.5 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Technology
12.1.6 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Disease
12.1.7 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By End User
12.1.8 North America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Countries
12.1.8.1 United States Hospital Acquired Urinary Tract Infection Market
12.1.8.1.1 United States Hospital Acquired Urinary Tract Infection Market by Product
12.1.8.1.2 United States Hospital Acquired Urinary Tract Infection Market by Application
12.1.8.1.3 United States Hospital Acquired Urinary Tract Infection Market by Technology
12.1.8.1.4 United States Hospital Acquired Urinary Tract Infection Market by Disease
12.1.8.1.5 United States Hospital Acquired Urinary Tract Infection Market by End User
12.1.8.2 Canada Hospital Acquired Urinary Tract Infection Market
12.1.8.2.1 Canada Hospital Acquired Urinary Tract Infection Market by Product
12.1.8.2.2 Canada Hospital Acquired Urinary Tract Infection Market by Application
12.1.8.2.3 Canada Hospital Acquired Urinary Tract Infection Market by Technology
12.1.8.2.4 Canada Hospital Acquired Urinary Tract Infection Market by Disease
12.1.8.2.5 Canada Hospital Acquired Urinary Tract Infection Market by End User
12.1.8.3 Mexico Hospital Acquired Urinary Tract Infection Market
12.1.8.3.1 Mexico Hospital Acquired Urinary Tract Infection Market by Product
12.1.8.3.2 Mexico Hospital Acquired Urinary Tract Infection Market by Application
12.1.8.3.3 Mexico Hospital Acquired Urinary Tract Infection Market by Technology
12.1.8.3.4 Mexico Hospital Acquired Urinary Tract Infection Market by Disease
12.1.8.3.5 Mexico Hospital Acquired Urinary Tract Infection Market by End User
12.1.8.4 US Hospital Acquired Urinary Tract Infection Market
12.1.8.4.1 US Hospital Acquired Urinary Tract Infection Market by Product
12.1.8.4.2 US Hospital Acquired Urinary Tract Infection Market by Application
12.1.8.4.3 US Hospital Acquired Urinary Tract Infection Market by Technology
12.1.8.4.4 US Hospital Acquired Urinary Tract Infection Market by Disease
12.1.8.4.5 US Hospital Acquired Urinary Tract Infection Market by End User
12.2. EUROPE
12.2.1 Europe Hospital Acquired Urinary Tract Infection Market Overview
12.2.2 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis
12.2.3 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Product
12.2.4 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Application
12.2.5 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Technology
12.2.6 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Disease
12.2.7 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By End User
12.2.8 Europe Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Hospital Acquired Urinary Tract Infection Market
12.2.8.1.1 Germany Hospital Acquired Urinary Tract Infection Market by Product
12.2.8.1.2 Germany Hospital Acquired Urinary Tract Infection Market by Application
12.2.8.1.3 Germany Hospital Acquired Urinary Tract Infection Market by Technology
12.2.8.1.4 Germany Hospital Acquired Urinary Tract Infection Market by Disease
12.2.8.1.5 Germany Hospital Acquired Urinary Tract Infection Market by End User
12.2.8.2 France Hospital Acquired Urinary Tract Infection Market
12.2.8.2.1 France Hospital Acquired Urinary Tract Infection Market by Product
12.2.8.2.2 France Hospital Acquired Urinary Tract Infection Market by Application
12.2.8.2.3 France Hospital Acquired Urinary Tract Infection Market by Technology
12.2.8.2.4 France Hospital Acquired Urinary Tract Infection Market by Disease
12.2.8.2.5 France Hospital Acquired Urinary Tract Infection Market by End User
12.2.8.3 Italy Hospital Acquired Urinary Tract Infection Market
12.2.8.3.1 Italy Hospital Acquired Urinary Tract Infection Market by Product
12.2.8.3.2 Italy Hospital Acquired Urinary Tract Infection Market by Application
12.2.8.3.3 Italy Hospital Acquired Urinary Tract Infection Market by Technology
12.2.8.3.4 Italy Hospital Acquired Urinary Tract Infection Market by Disease
12.2.8.3.5 Italy Hospital Acquired Urinary Tract Infection Market by End User
12.2.8.4 Spain Hospital Acquired Urinary Tract Infection Market
12.2.8.4.1 Spain Hospital Acquired Urinary Tract Infection Market by Product
12.2.8.4.2 Spain Hospital Acquired Urinary Tract Infection Market by Application
12.2.8.4.3 Spain Hospital Acquired Urinary Tract Infection Market by Technology
12.2.8.4.4 Spain Hospital Acquired Urinary Tract Infection Market by Disease
12.2.8.4.5 Spain Hospital Acquired Urinary Tract Infection Market by End User
12.2.8.5 United Kingdom Hospital Acquired Urinary Tract Infection Market
12.2.8.5.1 United Kingdom Hospital Acquired Urinary Tract Infection Market by Product
12.2.8.5.2 United Kingdom Hospital Acquired Urinary Tract Infection Market by Application
12.2.8.5.3 United Kingdom Hospital Acquired Urinary Tract Infection Market by Technology
12.2.8.5.4 United Kingdom Hospital Acquired Urinary Tract Infection Market by Disease
12.2.8.5.5 United Kingdom Hospital Acquired Urinary Tract Infection Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Overview
12.3.2 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis
12.3.3 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Application
12.3.5 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Technology
12.3.6 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Disease
12.3.7 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Hospital Acquired Urinary Tract Infection Market
12.3.8.1.1 Australia Hospital Acquired Urinary Tract Infection Market by Product
12.3.8.1.2 Australia Hospital Acquired Urinary Tract Infection Market by Application
12.3.8.1.3 Australia Hospital Acquired Urinary Tract Infection Market by Technology
12.3.8.1.4 Australia Hospital Acquired Urinary Tract Infection Market by Disease
12.3.8.1.5 Australia Hospital Acquired Urinary Tract Infection Market by End User
12.3.8.2 China Hospital Acquired Urinary Tract Infection Market
12.3.8.2.1 China Hospital Acquired Urinary Tract Infection Market by Product
12.3.8.2.2 China Hospital Acquired Urinary Tract Infection Market by Application
12.3.8.2.3 China Hospital Acquired Urinary Tract Infection Market by Technology
12.3.8.2.4 China Hospital Acquired Urinary Tract Infection Market by Disease
12.3.8.2.5 China Hospital Acquired Urinary Tract Infection Market by End User
12.3.8.3 India Hospital Acquired Urinary Tract Infection Market
12.3.8.3.1 India Hospital Acquired Urinary Tract Infection Market by Product
12.3.8.3.2 India Hospital Acquired Urinary Tract Infection Market by Application
12.3.8.3.3 India Hospital Acquired Urinary Tract Infection Market by Technology
12.3.8.3.4 India Hospital Acquired Urinary Tract Infection Market by Disease
12.3.8.3.5 India Hospital Acquired Urinary Tract Infection Market by End User
12.3.8.4 Japan Hospital Acquired Urinary Tract Infection Market
12.3.8.4.1 Japan Hospital Acquired Urinary Tract Infection Market by Product
12.3.8.4.2 Japan Hospital Acquired Urinary Tract Infection Market by Application
12.3.8.4.3 Japan Hospital Acquired Urinary Tract Infection Market by Technology
12.3.8.4.4 Japan Hospital Acquired Urinary Tract Infection Market by Disease
12.3.8.4.5 Japan Hospital Acquired Urinary Tract Infection Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Overview
12.4.2 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis
12.4.3 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Application
12.4.5 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Technology
12.4.6 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Disease
12.4.7 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Hospital Acquired Urinary Tract Infection Market
12.4.8.1.1 South Africa Hospital Acquired Urinary Tract Infection Market by Product
12.4.8.1.2 South Africa Hospital Acquired Urinary Tract Infection Market by Application
12.4.8.1.3 South Africa Hospital Acquired Urinary Tract Infection Market by Technology
12.4.8.1.4 South Africa Hospital Acquired Urinary Tract Infection Market by Disease
12.4.8.1.5 South Africa Hospital Acquired Urinary Tract Infection Market by End User
12.4.8.2 Saudi Arabia Hospital Acquired Urinary Tract Infection Market
12.4.8.2.1 Saudi Arabia Hospital Acquired Urinary Tract Infection Market by Product
12.4.8.2.2 Saudi Arabia Hospital Acquired Urinary Tract Infection Market by Application
12.4.8.2.3 Saudi Arabia Hospital Acquired Urinary Tract Infection Market by Technology
12.4.8.2.4 Saudi Arabia Hospital Acquired Urinary Tract Infection Market by Disease
12.4.8.2.5 Saudi Arabia Hospital Acquired Urinary Tract Infection Market by End User
12.4.8.3 U.A.E Hospital Acquired Urinary Tract Infection Market
12.4.8.3.1 U.A.E Hospital Acquired Urinary Tract Infection Market by Product
12.4.8.3.2 U.A.E Hospital Acquired Urinary Tract Infection Market by Application
12.4.8.3.3 U.A.E Hospital Acquired Urinary Tract Infection Market by Technology
12.4.8.3.4 U.A.E Hospital Acquired Urinary Tract Infection Market by Disease
12.4.8.3.5 U.A.E Hospital Acquired Urinary Tract Infection Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Hospital Acquired Urinary Tract Infection Market Overview
12.5.2 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis
12.5.3 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Product
12.5.4 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Application
12.5.5 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Technology
12.5.6 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Disease
12.5.7 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By End User
12.5.8 South and Central America Hospital Acquired Urinary Tract Infection Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Hospital Acquired Urinary Tract Infection Market
12.5.8.1.1 Brazil Hospital Acquired Urinary Tract Infection Market by Product
12.5.8.1.2 Brazil Hospital Acquired Urinary Tract Infection Market by Application
12.5.8.1.3 Brazil Hospital Acquired Urinary Tract Infection Market by Technology
12.5.8.1.4 Brazil Hospital Acquired Urinary Tract Infection Market by Disease
12.5.8.1.5 Brazil Hospital Acquired Urinary Tract Infection Market by End User
12.5.8.2 Argentina Hospital Acquired Urinary Tract Infection Market
12.5.8.2.1 Argentina Hospital Acquired Urinary Tract Infection Market by Product
12.5.8.2.2 Argentina Hospital Acquired Urinary Tract Infection Market by Application
12.5.8.2.3 Argentina Hospital Acquired Urinary Tract Infection Market by Technology
12.5.8.2.4 Argentina Hospital Acquired Urinary Tract Infection Market by Disease
12.5.8.2.5 Argentina Hospital Acquired Urinary Tract Infection Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. HOSPITAL ACQUIRED URINARY TRACT INFECTION MARKET, KEY COMPANY PROFILES
14.1. BD
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. STERIS PLC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GETINGE AB
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. KCWW
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. CANTEL MEDICAL
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. BIOMéRIEUX SA
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BELIMED
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. 3M
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. STERIGENICS U.S., LLC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. SYNERGY HEALTH
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
- Becton
- Dickinson and Company
- Steris Corporation
- Getinge Group
- Kimberly-Clark Corporation
- Cantel Medical
- Biomerieux SA
- Belimed AG
- 3M Company
- Sterigenics International LLC. ,
